International – AstraZeneca resumes trial of COVID-19 vaccine

AstraZeneca has confirmed that clinical trials assessing its Oxford University partnered coronavirus vaccine AZD1222 have resumed in the UK, following a green light by the Medicines Health Regulatory Authority (MHRA).

On September 6 the standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators, after one trial volunteer experienced an unexplained illness.

The UK committee has now concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume.

The drug giant said that it could not disclose further medical information but that all trial investigators and participants will be updated with the relevant information…